Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Other hematologic neoplasm 1

Conditions

Breast Neoplasms 2

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 214Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × valspodar × Breast × Clear all
NCT00002826 2023-06-07

Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
36 enrolled
Breast

Breast Neoplasms

NCT00002937 2010-01-06

Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer

City of Hope Medical Center

Phase 2 Completed
70 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡